163444-17-5

Basic information

• Product Name: 4-Amino-3-iodobenzotrifluoride
• Synonyms: BenzenaMine, 2-iodo-4-(trifluoroMethyl)-;4-amino-3-iodo-trifluoromethylbenzene;2-IODO-4-(TRIFLUOROMETHYL)ANILINE;4-(TRIFLUOROMETHYL)-2-IODOBENZENAMINE;4-AMINO-3-IODOBENZOTRIFLUORIDE;3-iodo-4-aminobenzotrifluoride;2-iodo-4-(trifluoroMethyl)benzenaMine;4-AMino-3-iodobenzotrifluoride[2-Iodo-4-(trifluoroMethyl)aniline]
• CAS NO: 163444-17-5
• Molecular Formula: C₇H₅F₃IN
• Molecular Weight: 287.02
• Product Categories: Aromatic Halides (substituted);API intermediates;Fluorine series
• Mol File: 163444-17-5.mol

Chemical Properties

• Melting Point: 50 °C
• Boiling Point: 252.8 °C at 760 mmHg
• Flash Point: 106.7 °C
• Appearance: /
• Density: 1.948 g/cm³
• Vapor Pressure: 0.019mmHg at 25°C
• Refractive Index: 1.57
• Storage Temp.: Room temperature.
• Solubility: soluble in Methanol
• PKA: 0.70±0.10(Predicted)
• CAS DataBase Reference: 4-Amino-3-iodobenzotrifluoride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Amino-3-iodobenzotrifluoride(163444-17-5)
• EPA Substance Registry System: 4-Amino-3-iodobenzotrifluoride(163444-17-5)

Safety Data

• Hazard Codes: Xi
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39-36/37
• HazardClass: IRRITANT
• Hazardous Substances Data: 163444-17-5(Hazardous Substances Data)

Usage

Chemical Properties

light brown powder

InChI:InChI=1/C7H5F3IN/c8-7(9,10)4-1-2-6(12)5(11)3-4/h1-3H,12H2

Upstream product

• 455-14-1 4-trifluoromethylphenylamine 
• 402-14-2 2-nitro-5-(trifluoromethyl)aniline 
• 16499-53-9 2-iodo-1-nitro-4-(trifluoromethyl)benzene 
• 878133-04-1 2,2,2-trifluoro-N-(2-iodo-4-(trifluoromethyl)phenyl)acetamide 

Downstream Products

• 163444-18-6 N-(2-iodo-4-trifluoromethylphenyl)-3-phenylpropanamide 
• 130656-70-1 1,2-diiodo-4-trifluoromethylbenzene 
• 496946-78-2 5-(trifluoromethyl)-1H-indole-2-carboxylic acid 
• 878133-04-1 2,2,2-trifluoro-N-(2-iodo-4-(trifluoromethyl)phenyl)acetamide 
• 6526-08-5 2-amino-5-(trifluoromethyl)benzonitrile 
• 117324-58-0 methyl 2-Amino-5-trifluoromethylbenzoate 
• 1093942-87-0 (S)-4-benzyl-3-(5-(trifluoromethyl)-1H-indol-2-yl)oxazolidin-2-one 
• 1068975-98-3 N-allyl-2-iodo-4-(trifluoromethyl)aniline 
• 1224635-29-3 2-{[2-(phenylethynyl)phenyl]ethynyl}-4-(trifluoromethyl)aniline 
• 1266246-20-1 C₁₄H₁₅F₃N₂Se 
• 1203588-23-1 N-(2-iodo-4-(trifluoromethyl)-phenyl)-3-(1,1-dimethylethyl)-benzene-sulfonamide 
• 1217302-63-0 ethoxy-N-[2-iodo-4-(trifluoromethyl)phenyl]carboxamide 
• 1058062-64-8 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzenamine 
• 1033002-26-4 2-(2-phenylethynyl)-4-trifluoromethylphenylamine 

Relevant articles and documents

Silicon-directed oxa-Pictet-Spengler cyclization and an unusual dimerization of 2-trimethylsilanyl tryptophols

(Chemical Equation Presented) The tetrahydro-pyrano[3,4-b]indoles 6 were synthesized from 2-(2-trimethylsilanyl-1H-indol-3-yl)-ethanols 5 and various ketones or aldehydes through silicon-directed oxa-Pictet-Spengler cyclizations. An unusual reaction led to the dimeric products 7 when some of 5 was treated with acetone using BF3 as the catalyst.

5, 10-dihydroindolo [3, 2-b] indole derivative and synthesis method and application thereof

The invention discloses a synthesis method of a 5, 10-dihydroindolo [3, 2-b] indole derivative, the method comprises the following steps: mixing a 2-((2-halogen phenyl) ethynyl)-N, N-dimethylaniline derivative (II), N, N-di-tert-butyl diazacycloketone (III), a palladium catalyst, a monophosphine ligand, alkali and a first organic solvent, and carrying out a diamidation reaction under the protection of inert gas to realize the synthesis of the 5, 10-dihydroindolo [3, 2-b] indole derivative(I). The method is easy to operate, mild in reaction condition and high in reaction yield, and the synthesized 5, 10-dihydroindolo [3, 2-b] indole derivative can be used for preparing an organic light-emitting device.

New indolo[1,2-c]quinazolines for single-crystal field-effect transistor: A united experimental and theoretical studies

Here, we account the synthesis and characterization of a series of symmetrical fused heterocyclic aromatic hydrocarbons (HAHs) with an indolo[1,2-c]quinazoline (IQ) as the core moiety. All the new HAHs IQ series were systematically investigated by using various spectroscopic methods. Furthermore, their photo-physical properties were supported by density functional theory (DFT) and time-dependent density functional theory (TDDFT) studies to support the experimental findings. The tetramethyl-substituted indolo[1,2-c]quinazoline (TMIQ) compound is shown to exhibit the shifted type of π–π stacking interactions, which render this series as a new semiconducting material. Single-crystal-based field-effect transistor devices of TMIQ exhibited efficient charge transport behavior, giving a p-channel field-effect mobility of 0.25 cm2?V?1?s?1 with an on/off ratio of 5 × 105.

SULFONYL-SUBSTITUTED BICYCLIC COMPOUND WHICH ACTS AS ROR INHIBITOR

Provided is a sulfonyl-substituted bicyclic compound (A) which acts as a RORγ inhibitor, said compound has good RORγ inhibitory activity and is expected to be used for treating diseases mediated by a RORγ receptor in mammals.

One-Pot Access to Benzo[a]carbazoles via Palladium(II)-Catalyzed Hetero- and Carboannulations

A Pd(II)-catalyzed direct synthesis of benzo[a]carbazoles has been achieved through aminopalladation of alkynes, followed by intramolecular nucleophilic addition of the generated carbon-palladium bond to a tethered cyano/aldehyde group. Compared to literature procedures, this synthetic approach is operationally simple, uses simple substrates, and offers a fast intramolecular assembly resulting in the direct synthesis of benzo[a]carbazoles in which a wide variation of substituents at different sites is well-tolerated, leaving enough opportunity for diversification.

METHOD FOR PROMOTING PLANT GROWTH

The present invention provides a method for promoting plant growth, which comprises treating a plant with at least one compound represented by the following Formula (1) The compounds indicated by formula (1) are used to promote the growth of plants. A pla

Gold(I)-catalyzed iodination of arenes

A wide variety of electron-rich arenes were efficiently converted into the corresponding iodinated compounds via a gold(I)-catalyzed reaction under mild conditions. Georg Thieme Verlag Stuttgart. New York.

Au-catalyzed formation of functionalized quinolines from 2-alkynyl arylazide derivatives

A new method for converting 2-alkynyl arylazide derivatives into functionalized polysubstituted quinolines following a gold-catalyzed 1,3-acetoxy shift/cyclization/1,2-group shift sequence has been developed. This transformation proceeds under mild reaction conditions, is efficient, and tolerates a large variety of functional groups.

NEW COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds. The compounds have the formula (A1) wherein R1, R2, R4, R6, E, n, Y1, Y2, Y3, Y4, Y5, L, B, R8, and m are as defined in the claims.

NOVEL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds. The compounds have the formula (A1), wherein R1, R2, R4, R5, R6, E, n, Y1, Y2, Y3, Y4, Y5, B, R8, and m are as defined in the claims.